fashion -WSS

fashion

author：knowledge 2025-09-29 13:31:00 - browse：522

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： New brain studies show LSD's effects on the brain in full color

WSS

EU regulator recommends expanding Mounjaro approval to obesity

Drug cartel violence flares in western Mexico after vigilante leader's killing

Beware reading your test results before your doctor does

Use doctors trained outside the U.S. to ease the physician shortage

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Beware reading your test results before your doctor does

knowledge

fashion

hotspot

At least 13 dead in Texas as scorching temps continue

Dewpoint Therapeutics lays off staff after losing partnerships

Psychedelics group wrestles with new pharma identity

Parkinson’s finding may lead to tests and, someday, treatments

Heart attack and stroke risk calculators need revising

Skip the lead apron during X

DIEP, the 'gold standard' of breast reconstruction, is under threat

AI generated plenty of interest at JPM but not a lot of trust

Duchenne breakthrough therapy leaves behind pioneering families

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

hotspot

Elizabeth Holmes banned from government health programs

New brain studies show LSD's effects on the brain in full color

The surgeon had a dilemma only a Nazi medical text could resolve

NIH director takes cautious approach to Biden drug pricing priority

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Beware reading your test results before your doctor does

leisure time

hotspot

knowledge

hotspot